Comparison of Analgesic Effectiveness of Ultrasound Guided Interscalene Block Versus Suprascapular With Axillary Block in Shoulder Arthroplasties
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 76
- 试验地点
- 1
- 主要终点
- Opioid (mg) consumption
研究概览
简要总结
In this study, the investigators are going to compare the analgesia effectiveness of interscalane block and suprascapular with axillary block in shoulder arthroplasties
详细描述
In the preoperative period, the participants will be taken to the block room. The participants will be monitored, standard sedation will be applied.
The first group will be get interscalene block. The second group will be get suprascapular and axillary block. The third group patient will be get no block. Afterwards, the participants will be operated under general anesthesia. A patient-controlled analgesia device will be attached to each group of participants and their postoperative follow-up will be made.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
盲法说明
open
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •accepting the study protocol,
- •age older than 18 years and younger than 90 years,
- •undergoing shoulder arthroplasty surgery
- •the American Society of Anesthesiologist (ASA) physical status of I-II-III-IV
排除标准
- •severe respiratory distress
- •patients with local anesthetic allergy
- •contralateral hemidiaphragmatic parrhesia
- •recurrent laryngeal nerve palsy
- •infection at the injection site
- •coagulation disorder
研究组 & 干预措施
Study group: interscalene block + IV PCA
preop usg guided interscalene block and IV PCA
干预措施: interscalene block (Procedure)
Study group: suprascapular block + axillary block + IV PCA
preop usg guided suprascapular block + axillary block and IV PCA
干预措施: suprascapular block + axillary block (Procedure)
Control group: IV PCA
no block + IV PCA
结局指标
主要结局
Opioid (mg) consumption
时间窗: 48 hours
Opioid (mg) consumption
Measurement of postoperative pain
时间窗: 48 hours
VAS (visual analog scale) (0: no pain, 10: the worst pain imaginable)
次要结局
未报告次要终点
研究者
Nur Canbolat
Principal Investigator, M.D.
Istanbul University